Friday, June 2, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

SRC to Support DTRA in Characterizing Chemical Threat Agents

by Global Biodefense Staff
October 22, 2015

The U.S. Defense Threat Reduction Agency (DTRA) this week announced intentions to award a sole source contract for chemical threat agent characterization to SRC, Inc.

This is a follow-on research contract to complete a set of models for characterizing chemical agent fate of both traditional and non-traditional chemical warfare agents, including long term environmental response and evaporative and contact hazards in operationally relevant conditions.

The models will be transitioned to the Joint Effects Model (JEM) program of record and the JEM S&T Prototype/Hazard Prediction and Assessment Capability for integration.

The overall objective of JEM is to provide a single, validated capability to predict and track events and effects from nuclear, biological and chemical agents as well as toxic industrial chemicals.

An operational version of JEM will reside on DoD Command, Control, Communications, Computers and Intelligence (C4I) platforms and will interface with existing and planned warning systems, weather data, messages, and support deliberate planning and analysis.

The period of performance for the SRC contract is estimated to be 25 months.

Tags: AwardsModeling-Simulation

Related Posts

Vials of finished vaccines
Funding News

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Medical Countermeasures

Scientists Design Molecule to Slow SARS-Cov-2 Infection

March 29, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Load More

Latest News

Vials of finished vaccines

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

April 26, 2023
Biodefense Headlines – 25 April 2023

Biodefense Headlines – 25 April 2023

April 25, 2023
Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

April 20, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2023 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2023 Stemar Media Group LLC